The global constipation treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The constipation treatment market will show rapid growth due to factors such as the increasing geriatric population and changing dietary habits, high prevalence of IBS-C, OIC, and chronic constipation, and the development of the latest drugs and treatment procedures. Irritable bowel syndrome (IBS) is found to be a chronic, recurring, and remitting functional disorder of the gastrointestinal tract that causes abdominal pain, distention, and changes in bowel habits. Irritable bowel syndrome (IBS) is found to affect up to 7%–18% of the population globally and therefore its prevalence is increasing that is driving the overall market growth. Although there are several drugs for IBS in the market that are effective and approved treatments for one or more of the symptoms for various IBS. There are also newer pharmacological treatments being available for constipation that is superior to placebo in relieving constipation. However, there is no single approach to treat IBS-C. Often, people use a mix of therapies to get relief. They can include changes in diet, exercise, stress management, and medication. Hence all these factors are associated with the increase in the overall growth of the market.

Constipation is a common medical condition that affects the normal life of an individual, and prolonged constipation could be a symptom of more severe diseases and disorders. It is estimated to affect every one individual once in a lifetime. Constipation may be occasional which lasts for a few weeks or maybe chronic which lasts for a longer period and is recurrent. Therefore, it may be associated with other conditions such as irritable bowel syndrome or opioid consumption also. 

On the basis of therapeutic options, the global constipation treatment market is segmented into laxatives, peripherally acting mu-opioid receptor antagonists, chloride channel activators, GC-C agonists, and others. Laxatives are a type of medicine that can treat constipation. They're often used if lifestyle changes, when increasing the amount of fiber in the diet, drinking plenty of fluid, and taking regular exercise, have not helped. Therefore, the laxatives segment is anticipated to be most promising treatment for constipation. In addition, low cost and wide availability are two key factors that results in the potential share of the laxatives segment.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Takeda Pharmaceutical Company Ltd., Ironwood Pharmaceuticals, Inc., and AstraZeneca Plc., among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Constipation Treatment Market Report by Segment

By Treatment

• Laxatives

• Chloride Channel Activators

• Peripherally Acting Mu-Opioid Receptor Antagonists

• GC-C Agonists

• Others

By Disease Type

• Chronic Idiopathic Constipation (CIC)

• Irritable Bowel Syndrome with Constipation (IBSC)

• Opioid-Induced Constipation (OIC)

Global Constipation Treatment Market by Region